UPDATE: JPMorgan Downgrades Rigel Pharmaceuticals (RIGL) to Neutral
Tweet Send to a Friend
(Updated - November 9, 2020 5:43 AM EST)
(updating comment)JPMorgan analyst Tessa Romero downgraded Rigel Pharmaceuticals (NASDAQ: RIGL) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
(updating comment)JPMorgan analyst Tessa Romero downgraded Rigel Pharmaceuticals (NASDAQ: RIGL) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE